• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

    4/23/25 4:00:00 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email

    New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations

    LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360—a solution designed to empower medtech companies with advanced insights to drive commercial performance. As the demand for precise, analytics-driven strategies grows, medtech companies require deeper visibility into customer activity, affiliations, practice behavior and caseloads. DRG Commercial Analytics 360 equips commercial teams with the insights needed to navigate the complex U.S. provider landscape, engage key stakeholder, and improve both patient access and business outcomes.

    Clarivate logo (PRNewsfoto/Clarivate Analytics)

    Tailored for the medtech sector, the platform combines the robust search capabilities of Procedure Finder with the extensive Clarivate provider and affiliations network. It delivers real-world, data-driven intelligence, enabling medtech companies to optimize strategic planning, field sales performance and market execution.

    Juliane Ray, Vice President, Product Management, Medtech, Life Sciences & Healthcare, Clarivate, said: "DRG Commercial Analytics 360 was purpose-built to help medtech companies translate real-world data into smarter, more agile commercial strategies. By enabling precise omnichannel targeting, seamless integration and intelligent bundling, the platform provides the accuracy and granularity needed to navigate today's complex provider landscape. With insights mastered at the market segment level, our customers can uncover new opportunities and make confident, data-driven decisions that advance both business goals and patient access."

    Theo McCormick, Senior Manager Pricing & Analytics, Bioventus, Inc., said: "Understanding the data has helped to shape our strategy, instead of chasing competitors, we're now looking at clinicians differently. The data is helping to change our conversations with physicians to include the business leaders of healthcare systems."

    To meet the evolving demands of complex targeting in medtech, DRG Commercial Analytics 360 delivers a suite of capabilities that enable smarter, data-driven decisions across the commercial organization:

    • Actionable Intelligence: Integrated healthcare provider data and analytics offer clear, tailored insights into who is treating targeted patients, their network affiliations, and where procedures are performed—across hospitals, ambulatory surgery centers, and other care settings.
    • Accurate, De-duplicated Market Segments: By categorizing procedures by type and eliminating code-level duplication, the platform ensures a reliable, detailed view of procedure volume and flow across the U.S. market.
    • 360˚ Market Visibility: Modularized claims and code groupings are aligned with precise market definitions to support accurate market sizing and informed resource allocation.
    • Expert-Led Data Intelligence: Backed by in-house medtech, medical coding, and U.S. healthcare expertise, Clarivate data scientists apply tailored extrapolation methodologies to surface nuanced insights across market segments.

    The Clarivate medtech team partners with medical device companies and distributors to fully harness the value of DRG Commercial Analytics 360—whether building national strategy or optimizing field sales planning. To learn more about DRG Commercial Analytics 360, visit here.

    About Clarivate

    Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com 

    Media Contact:

    Luna Ivkovic

    External Communications, Life Sciences & Healthcare

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-launches-drg-commercial-analytics-360-enabling-medtech-companies-to-advance-commercial-strategy-and-execution-302434609.html

    SOURCE Clarivate Plc

    Get the next $CLVT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    8/25/2023$9.00 → $8.00Outperform → Sector Perform
    RBC Capital Mkts
    8/7/2023$10.00 → $6.00Neutral → Underperform
    BofA Securities
    8/4/2023$15.00 → $8.00Overweight → Equal Weight
    Wells Fargo
    6/13/2023$11.00Outperform
    Oppenheimer
    More analyst ratings

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Snyder Andrew Miles bought $989,024 worth of Ordinary Shares (237,176 units at $4.17) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/18/25 4:56:10 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun bought $200,492 worth of Ordinary Shares (49,750 units at $4.03) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/14/25 4:14:29 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Pritchett Wendell E. bought $100,114 worth of Ordinary Shares (22,857 units at $4.38), increasing direct ownership by 47% to 71,835 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/5/25 4:17:24 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments

      New AI-based solution empowers trademark professionals to evaluate trademark risk and generate evidence-backed arguments with speed, ease, and confidence LONDON, May 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of RiskMark, an AI-powered solution combining global CompuMark trademark data and Darts-ip litigation data to evaluate trademark risk. Leveraging 172.5 million trademark records spanning 188 jurisdictions and over 5 million global court and administrative records, RiskMark combi

      5/19/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Report Reveals Top Trademark Portfolios

      Procter & Gamble, Nestlé, Apple, L'Oréal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON, May 15, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Trademark filing trends 2025 report, analyzing ten key trademark registers worldwide: the United States (U.S.), Canada, the United Kingdom (U.K.), the European Union (EU), France, Germany, India, Mainland China, Japan, and Australia. The report reveals the top 20 largest local and foreign-based trademark portfolios in each region and the law firms managing the largest trademark portfolios.

      5/15/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments

      R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development using new visual and data-driven insights LONDON, May 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection process. Pathway Maps provide powerful visual tools that offer deeper insights into the biologic

      5/14/25 4:00:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Clarivate downgraded by William Blair

      William Blair downgraded Clarivate from Outperform to Mkt Perform

      11/6/24 8:22:43 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00

      12/15/23 8:04:33 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate upgraded by Jefferies with a new price target

      Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously

      10/16/23 9:11:50 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Financials

    Live finance-specific insights

    See more

    $CLVT
    Leadership Updates

    Live Leadership Updates

    See more

    $CLVT
    SEC Filings

    See more

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Clarivate Reports First Quarter 2025 Results

      — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

      4/29/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate to Report First Quarter 2025 Results on April 29, 2025

      LONDON, April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, April 29, 2025 to review the results. The webcast is open to all interested

      4/2/25 8:05:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Reports Fourth Quarter and Full Year 2024 Results

      — Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON, Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024.

      2/19/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

      Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

      4/26/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Names Bar Veinstein as President, Academia & Government

      Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

      4/19/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

      Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

      3/23/23 4:30:00 PM ET
      $CLVT
      $CNTA
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Clarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      5/19/25 4:49:39 PM ET
      $CLVT
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Clarivate Plc

      SCHEDULE 13G/A - CLARIVATE PLC (0001764046) (Subject)

      5/14/25 4:29:43 PM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      5/12/25 4:46:05 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Alberola Valeria was granted 39,473 units of Ordinary Shares and covered exercise/tax liability with 6,042 units of Ordinary Shares, increasing direct ownership by 58% to 91,158 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:45 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Saha Saurabh covered exercise/tax liability with 4,974 units of Ordinary Shares and was granted 39,473 units of Ordinary Shares, increasing direct ownership by 42% to 116,515 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:34 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun covered exercise/tax liability with 1,722 units of Ordinary Shares and was granted 39,473 units of Ordinary Shares, increasing direct ownership by 22% to 207,290 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:25 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Clarivate Plc

      SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

      12/5/24 10:02:09 AM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13G filed by Clarivate Plc

      SC 13G - CLARIVATE PLC (0001764046) (Subject)

      11/13/24 4:18:30 PM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

      SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

      3/4/24 9:01:44 AM ET
      $CLVT
      EDP Services
      Technology